Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: TOL2506|DRUG: Tamoxifen|DRUG: Letrozole Tablets|DRUG: Anastrozole Tablets|DRUG: Exemestane Tablets
Sponsor: Tolmar Inc.